https://pipelinereview.com/data-from-agios-phase-3-claridhy-trial-of-tibsovo-demonstrates-significant-improvement-in-progression-free-survival-pfs-compared-to-placebo-in-previously-treated-idh1-mutant-cholangiocarcinoma-patient/
Data from Agios’ Phase 3 ClarIDHy Trial of TIBSOVO® Demonstrates Significant Improvement in Progression Free Survival (PFS) Compared to Placebo in Previously Treated IDH1 Mutant Cholangiocarcinoma Patients